The management of acute severe colitis: ACPGBI position statement

Colorectal Disease

Volumn 10, Issue SUPPL. 3, 2008, Pages 8-29

  Brown, Steve R ^a,d   Haboubi, N ^b   Hampton, J ^a   George, B ^c   Travis, S P L ^c  

^a SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b NATIONAL HEALTH SERVICE   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; BETAMETHASONE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIPROFLOXACIN; CORTICOSTEROID; CYCLOSPORIN A; HEPARIN; HYDROCORTISONE; INFLIXIMAB; MESALAZINE; METHYLPREDNISOLONE; METRONIDAZOLE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; STEROID; TACROLIMUS; TOBRAMYCIN; VANCOMYCIN; VISILIZUMAB;

ABDOMINAL RADIOGRAPHY; ARTICLE; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; COLITIS; COLON RESECTION; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CROHN DISEASE; CYTOMEGALOVIRUS INFECTION; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG SAFETY; ERYTHROCYTE SEDIMENTATION RATE; EVIDENCE BASED MEDICINE; GASTROINTESTINAL ENDOSCOPY; HEMATOCHEZIA; HISTOPATHOLOGY; HUMAN; HYPERTENSION; HYPOMAGNESEMIA; ILEOSTOMY; LAPAROSCOPIC SURGERY; LOW DRUG DOSE; MONOTHERAPY; NEPHROTOXICITY; NUTRITIONAL SUPPORT; OPERATION DURATION; PHYSICAL EXAMINATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROCTOCOLECTOMY; PROGNOSIS; REMISSION; SEIZURE; SIGMOIDOSCOPY; SINGLE DRUG DOSE; SURGICAL TECHNIQUE; THROMBOEMBOLISM; TOXIC MEGACOLON; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

COLECTOMY; COLITIS; GREAT BRITAIN; HEALTH PLANNING GUIDELINES; HUMANS; ILEOSTOMY; LAPAROSCOPY; LENGTH OF STAY; POSTOPERATIVE COMPLICATIONS; TIME FACTORS; TREATMENT OUTCOME;

EID: 54449100426     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2008.01682.x     Document Type: Article

References (136)

1. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Gut 1963; 4: 299-315.
2. Hawthorne AB, Travis SPL, the BSG IBD Clinical Trials Network. Outcome of inpatient management of severe ulcerative colitis: A BSG IBD Clinical Trials Network Survey. Gut 2002; 50: A16.
3. Don BA, Goldacre MJ. Absence of seasonality in emergency hospital admissions for inflammatory bowel disease. Lancet 1984; 2: 1156-7.
4. Hardy TL, Bulmer E. Ulcerative colitis: Survey of 95 cases. Br Med J 1933; ii: 812-5.
5. Miller CG, Gardner CMcG, Ripstein CB. Primary resection of the colon in ulcerative colitis. Can Med Assoc J 1949; 60: 584.
6. Rice-Oxley JM, Truelove SC. Ulcerative colitis: Course and prognosis. Lancet 1950; i: 663 -6.
7. Truelove SC, Witts LJ. Cortisone in ulcerative colitis: Final report on a therapeutic trial. Br Med J 1955; ii: 1041-8.
8. Travis SPL, Farrant JM, Ricketts C et al. Predicting outcome in severe ulcerative colitis. Gut 1996; 38: 905-10.
9. Turner D, Walsh C, Steinhart AH, Griffiths AM. Response to corticosteroids in severe ulcerative colitis: A systematic review of the literature and a meta-regression. Clin Gastroenterol Hepatol 2007; 5: 103-10.
10. Stenner JMC, White P, Gould SR, Lim AG. Audit of the management of severe ulcerative colitis in a DGH. Gut 2001; 48: A87.
11. Eccles M, Mason J. How to develop cost-conscious guidelines. Health Technol Assess 2001; 5: 1-69.
12. Mann T. (1996) Clinical Guidelines: Using Clinical Guidelines to Improve Patient Care Within the NHS. NHS Executive, London.
13. Rutgeerts P, Sandborn WJ, Feagan B et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005; 233: 2462-73.
14. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology Practice and Parameters committee. Am J Gastroenterol 2004; 99: 1371-85.
15. Travis SPL, Strange E, Lémann M et al. Europa evidence based consensus on the management of ulcerative colitis 2007. J Crohn's Colitis 20: 2: -24.
16. Carter MJ, Lobo AJ, Travis SPL et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004; 53 (Suppl. 5): V1-16.
17. Orlandi F, Brunelli E, Feliciangeli G et al. Observer agreement in endoscopic assessment of ulcerative colitis. Ital J Gastroenterol Hepatol 1998; 30: 539-41.
18. Carbonnel F, Lavergne A, Lemann M et al. Colonoscopy in acute colitis: A safe and reliable tool for assessment of severity. Dig Dis Sci 1994; 39: 1550-7.
19. Lennard Jones JE, Ritchie JK, Hilder W, Spicer CC. Assessment of severity in colitis: A preliminary study. Gut 1975; 16: 579-84.
20. Lindgren SC, Flood LM, Kilander AF et al. Early predictors of glucocorticoid treatment failure in severe and moderately severe attacks of ulcerative colitis. Eur J Gastroenterol Hepatol 1998; 10: 831-5.
21. Turner D, Walsh CM, Chow C et al. Intravenous corticosteroid therapy for severe pediatric ulcerative colitis: Predictors of response and outcome. Gastroenterology 2007; 132 (Suppl. 2): A-514.
22. Benazzato L, D'Inca R, Grigoletto F et al. Prognosis of severe attacks in ulcerative colitis: Effect of intensive medical treatment. Dig Liver Dis 2004; 36: 461-6.
23. Ho GT, Mowat C, Goddard CJ et al. Predicting the outcome of severe ulcerative colitis: Development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. Aliment Pharmacol Ther 2004; 19: 1079-87.
24. Roussomoustakaki M, Satsangi J, Welsh K et al. Genetic markers may predict disease behaviour in patients with ulcerative colitis. Gastroenterology 1997; 112: 1845-53.
25. Ho GT, Nimmo ER, Tenesa A et al. Allelic variations of the multidrug resistance gene determine susceptibility and disease behaviour in ulcerative colitis. Gastroenterology 2005; 128: 288-96.
26. Schmidt CM, Lazenby AJ, Hendrickson RJ, Sitzmann JV. Preoperative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure. Ann Surg 1998; 227: 654-62.
27. Fenoglio Preiser C, Noffsinger AE, Stemmermann GN, Lantz PE, Listrom MB, Rilke FO (eds). (1999 2nd edition) Gastrointestinal Pathology: An Atlas and Text. Lippincott Williams, London.
28. D'Haens G, Geboes K, Peeters M, Baert F, Ectors N, Rutgeerts P. Patchy caecal inflammation associated with distal ulcerative colitis; a prospective endoscopic study. Am J Gastroenterol 1997; 92: 1275-9.
29. Haboubi NY, Schofield PF. Large bowel biopsies in colitis: A clinic pathological collaboration. J R Soc Med 1994; 87: 16.
30. Haboubi NY, Schofield PF. Reporting colonic mucosal biopsies in inflammatory conditions: A new approach. Colorectal Dis 2000; 2: 66-724.
31. Haboubi NY, Shaath NM, Safarani F. Improved diagnostic accuracy of inflammatory bowel disease: A clinico-pathological approach. Tech Coloproctol 2004; 8: 117-21.
32. Absar S, Mason J, Anjum K, Haboubi NY. A new combined form significantly improves accuracy of pathological diagnosis in inflammatory bowel disease in absence of the clinicopathological conference. Tech Coloproctol 2006; 10: 227-32.
33. Takahashi T, Gamboa-Dominguez A, Gomez-Mendez TJM, Remes JM, Rembis V, Martinez-Gonzalez D, Gutierrez-Saldivar J, Morales JC, Granados J, Sierra-Madora J. Fulminant amoebic colitis: Analysis of 55 cases. Dis Colon Rectum 1997; 40: 1362-7.
34. Vyas SK, Law NN, Hill S, Leohri CA. Toxic megacolon with late perforation in campylobacter colitis: A cautionary tale. Postgrad Med J 1993; 69: 322-4.
35. Criscuoli V, Casa A, Orlando A et al. Severe acute colitis associated with CMV: A prevalence study. Dig Liver Dis 2004; 36: 818-20.
36. Thoeni RF, Cello JP. CT imaging of colitis. Radiology 2006; 240: 623-38.
37. Fisher JK. Abnormal colonic wall thickening on computed tomography. J Comput Assist Tomogr 1983; 7: 90-7.
38. Gore RM, Balthazar EJ, Ghahremani GG, Miller FH. CT features of ulcerative colitis and Crohn's disease. Am J Roentgenol 1996; 167: 3-15.
39. Philpotts LE, Heiken JP, Westcott MA, Gore RM. Colitis: Use of CT findings in differential diagnosis. Radiology 1994; 190: 445-9.
40. Fishman EK, Kavuru M, Jones B et al. Pseudomembranous colitis: CT evaluation of 26 cases. Radiology 1991; 180: 57-60.
41. Ramachandran I, Sinha R, Rodgers PM. Pseudomembranous colitis revisited: spectrum of imaging findings. Clin Radiol 2006; 61: 535-44.
42. Morris JB, Zollinger RM, Stellato TA. Role of surgery in antibiotic-induced pseudomembranous enterocolitis. Am J Surg 1990; 160: 535-9.
43. Jobe BA, Grasley A, Deveney KE et al. Clostridium difficile colitis: An increasing hospital acquired illness. Am J Surg 1995; 169: 480-3.
44. Kawamoto S, Horton KM, Fishman EH. Pseudomembranous colitis: Spectrum of imaging findings with clinical and pathologic correlation. Radiographics 1999; 19: 887-97.
45. Imbriaco M, Balthazar EJ. Toxic megacolon: Role of CT in evaluation and detection of complications. Clin Imaging 2001; 25: 349-54.
46. Ahualli J. The target sign: Bowel wall. Radiology 2005; 234: 549-50.
47. Balthazar EJ. CT of the gastrointestinal tract: Principles and interpretation. Am J Roentgenol 1991; 156: 23-32.
48. Wittenberg J, Harisinghani MG, Jhaveri K et al. Algorithmic approach to CT diagnosis of the abnormal bowel wall. Radiographics 2002; 22: 1093-109.
49. Horton KM, Corl FM, Fishman EK. CT evaluation of the colon: Inflammatory disease. Radiographics 2000; 20: 399-418.
50. Macari M, Chandarana H, Balthazar EJ, Babb J. Intestinal ischemia versus intramural hemmorhage: CT evaluation. Am J Roentgenol 2003; 180: 177-84.
51. O'Sullivan SG. The accordion sign. Radiology 1998; 206: 177-8.
52. Ros PR, Buetow PC, Pantograg-Brown L et al. Pseudomembranous colitis. Radiology 1996; 198: 1-9.
53. Macari M, Balthazar EJ, Megibow AJ. The accordion sign at CT: A non-specific finding in patients with colonic edema. Radiology 1999; 211: 743-6.
54. Gayer G, Apter S, Zissin R. Typhlitis as a rare cause of psoas abscess. Abdom Imaging 2002; 27: 600-2.
55. Balthazar EJ, Yen BC, Gordon RB. Ischemic colitis: CT evaluation of 54 cases. Radiology 1999; 211: 381-8.
56. Rice RP. Plain abdominal film roentgenographic diagnosis of ulcerative disease of the colon. Am J Roentgenol 1968; 104: 544-50.
57. McConnell F, Hanelin J, Robbins LL. Plain film diagnosis of fulminating ulcerative colitis. Radiology 1958; 71: 674-82.
58. Bartram CI. Plain abdominal X-ray in acute colitis. Proc R Soc Med 1976; 69: 617-8.
59. Brooke BN, Sampson PA. An indication for surgery in acute ulcerative colitis. Lancet 1964; 2: 1272.
60. Bartram CI, Thompson T, Price AB. (1983) In: Radiology in Inflammatory Bowel Disease, 1st edn, pp. 31-61. Marcel Decker, New York.
61. Chew CN, Nolan DJ, Jewell DP. Small bowel gas in ulcerative colitis. Gut 1991; 32: 1535-7.
62. Latella G, Vernia P, Viscido A et al. GI distension in severe ulcerative colitis. Am J Gastroenterol 2002; 97: 1169-75.
63. Caprilli R, Vernia P, Latella G, Torsoli A. Early recognition of toxic megacolon. J Clin Gastroenterol 1987; 9: 160-4.
64. Almer S, Bodemar G, Franzen L et al. Use of air enema radiography to assess depth of ulceration during acute attacks of ulcerative colitis. Lancet 1996; 347: 1731-5.
65. Marshak RH, Lester LJ, Freidman AI. Megacolon, a complication of ulcerative colitis. Gastroenterology 1950; 16: 768-72.
66. Sheth SG, LaMont JT. Toxic megacolon. Lancet 1998; 351: 509-13.
67. Hywel Jones J, Chapman M. Definition of megacolon in colitis. Gut 1969; 10: 562-4.
68. Gan SI, Beck PL. A new look at toxic megacolon: An update and review of incidence, etiology, pathogenesis, and management. Am J Gastroenterol 2003; 98: 2363-71.
69. Oldfield EC III. Clostridium difficile -associated diarrhea: Resurgence with a vengeance. Rev Gastroenterol Disord 2006; 6: 79-96.
70. Wolf BS, Marshak RH. "Toxic" segmental dilatation of the colon during the course of fulminating ulcerative colitis: Roentgen findings. Am J Roentgenol 1959; 82: 985-95.
71. Kramer P, Wittenberg J. Colonic gas distribution in toxic megacolon. Gastroenterol 1981; 80: 433-7.
72. Rosenberg W, Ireland A, Jewell DP. High-dose methylprednisolone in the treatment of active ulcerative colitis. J Clin Gastroenterol 1990; 12: 40-1.
73. Bossa F, Fiorella S, Caruso N et al. Continuous infusion versus bolus administration of steroids in severe attacks of ulcerative colitis: A randomized, double-blind trial. Am J Gastroenterol 2007; 102: 601-8.
74. Jakobovits S, Travis SPL. The management of acute severe ulcerative colitis. Br Med Bull 2006; 76: 131-44.
75. Truelove SC, Jewell DP. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet 1974; i: 1067-70.
76. Michell NP, Lalor P, Langman MJ. Heparin therapy for ulcerative colitis? Effects and mechanisms. Eur J Gastroenterol Hepatol 2001; 13: 449-56.
77. Gonzalez-Huix F, Fernandez-Banares F, Esteve-Comas M et al. Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitis. Am J Gastroenterol 1993; 88: 227-32.
78. McIntyre PB, Powell-Tuck J, Wood SR et al. Controlled trial of bowel rest in the treatment of severe acute colitis. Gut 1986; 27: 481-5.
79. Chapman RW, Selby WS, Jewell DP. Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. Gut 1986; 27: 1210-2.
80. Mantzaris GJ, Petraki K, Archavlis E et al. A prospective randomized controlled trial of intravenous ciprofloxacin as an adjunct to corticosteroids in acute, severe ulcerative colitis. Scand J Gastroenterol 2001; 36: 971-4.
81. Lichtiger S, Present DH, Kornbluth A, Gelernt I. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994; 330: 1841-5.
82. Cohen RD, Stein R, Hanauer SB. Intravenous cyclosporine in ulcerative colitis: A five year experience. Am J Gastroenterol 1999; 94: 1587-92.
83. Campbell S, Travis SPL, Jewell DP. Ciclosporin use in acute ulcerative colitis: A long-term experience. Eur J Gastroenterol Hepatol 2005; 17: 79-84.
84. Moskovitz DN, Van Assche G, Maenhout B et al. Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis. Clin Gastroenterol Hepatol 2006; 4: 760-5.
85. Van Assche G, D'Haens G, Noman M et al. Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterology 2003; 125: 1025-31.
86. D'Haens G, Lemmens L, Gebboes K et al. Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology 2001; 120: 1323-9.
87. Shibolet O, Regushevskaya E, Brevis M, Soares-Weiser K. Cyclosporine A for induction of remission in severe ulcerative colitis. Cochrane Database Syst Rev 2005; 1: CD0004277.
88. Poritz LS, Rowe WA, Swenson BR, Hollenbeak CS, Koltun WA. Intravenous cyclosporine for the treatment of severe steroid refractory ulcerative colitis: What is the cost? Dis Colon Rectum 2005; 48: 1685-90.
89. Hyde GM, Jewell DP, Kettlewell MGW, Mortensen NJ. Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications. Dis Colon Rectum 2001; 44: 1436-40.
90. Järnerot G, Hertervig E, Friis-Liby I et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: A randomized, placebo-controlled study. Gastroenterology 2005; 128: 1805-11.
91. Seo M, Okada M, Yao T et al. An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol 1992; 87: 971-6.
92. Sands BE, Tremaine WJ, Sandborn WJ et al. Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: A pilot study. Inflamm Bowel Dis 2001; 7: 83-8.
93. Kaser A, Mairinger T, Vogel W, Tilg H. Infliximab in severe steroid-refractory ulcerative colitis: A pilot study. Wien Klin Wochenschr 2001; 113: 930-3.
94. Kohn A, Prantera C, Pera A, Cosintino R, Sostegni R, Daperno M. Anti-tumour necrosis factor alpha (infliximab) in the treatment of severe ulcerative colitis: Result of an open study on 13 patients. Dig Liver Dis 2002; 34: 626-30.
95. Regueiro M, Curtis J, Plevy S. Infliximab for hospitalized patients with severe ulcerative colitis. J Clin Gastroenterol 2006; 40: 476-81.
96. Jakobovits S, Jewell DP, Travis SPL. Infliximab for the treatment of ulcerative colitis: Outcomes in Oxford from 2000 to 2006. Aliment Pharmacol Ther 2007; 25: 1055-60.
97. Colombel JF, Loftus EV Jr, Tremaine WJ et al. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 2004; 99: 878-83.
98. Lees CW, Heys D, Shand AG et al. Infliximab as rescue therapy in acute severe UC: A survey of the Scottish society of Gastroenterology (SSG). J Crohn's Colitis 2007; 1: 34 [abstract].
99. Maser EA, Deconda D, Lichtiger S, Present DH, Kornbluth A. Cyclosporine and infliximab as acute salvage therapies for each other, in severe steroid-refractory ulcerative colitis. Gastroenterology 2007; 132 (Suppl. 2): S1132 (abstract).
100. Ogata H, Matsui T, Nakamura M et al. A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis. Gut 2006; 55: 1255-62.
101. Fellerman K, Tanko Z, Herrlinger KR et al. Response of refractory colitis to intravenous or oral tacrolimus (FK506). Inflamm Bowel Dis 2002; 8: 478-9.
102. Baumgart DC, Wiedenmann B, Dignass AU. Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease. Aliment Pharmacol Ther 2003; 17: 1273-81.
103. Hogenauer C, Wenzl HH, Hinterleitner TA, Petritsch W. Effect of oral tacrolimus (FK506) on steroid-refractory moderate/severe ulcerative colitis. Aliment Pharmacol Ther 2003; 18: 415-23.
104. Plevy S, Salzberg B, Van Assche G et al. A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis. Gastroenterology 2007; 133: 1414-22.
105. Hanai H, Iida T, Watanabe F et al. Intensive granulocyte and monocyte apheresis versus intravenous prednisolone in patients with severe ulcerative colitis: A multicentre randomized controlled study. Gut 2006; 55 (Suppl. II): A1.
106. Goodman MJ, Truelove SC. Intensive intravenous regimen for membranous colitis. Br Med J 1976; 2: 354.
107. Bojic D, Al-Ali M, Jewell DP, Nedeljkovic-Protic M, Travis SPL. Pattern and outcome of severe ulcerative colitis: 15 year data. Gut 2005; 54 (Suppl. VII): A155.
108. Edwards C, George B, Jewell DP, Warren BF, Mortensen N, Kettlewell M. The role of a defunctioning stoma in the management of large bowel Crohn's disease. Br J Surg 2000; 87: 1063-6.
109. Ziv Y, Fazio VW, Church JM, Milsom JW, Schroeder TK. Safety of urgent restorative proctocolectomy with ileal pouch-anal anastomosis for fulminant colitis. Dis Colon Rectum 1995; 38: 345-9.
110. Harms BA, Myers GA, Rosenfeld DJ, Starling JR. Management of fulminant ulcerative colitis by primary restorative proctocolectomy. Dis Colon Rectum 1994; 37: 971-8.
111. Heyvaert G, Penninchx F, Filez L, Aerts R, Kerremans R, Rutgeerts P. Restorative proctocolectomy in elective and emergency cases of ulcerative colitis. Int J Colorect Dis 1994; 9: 73-6.
112. Binder SC, Miller HH, Deterling RA. Emergency and urgent operations for ulcerative colitis. Arch Surg 1975; 110: 284-9.
113. Alves A, Panis Y, Bouhnik Y, Maylin V, Lavergne-Slove A, Valleur P. Subtotal colectomy for severe acute colitis: A 20-year experience of a tertiary care center with an aggressive and early surgical policy. J Am Coll Surg 2003; 197: 379-85.
114. Berg DF, Bahadursingh AM, Kaminski DL, Longo WE. Acute surgical emergencies in inflammatory bowel disease. Am J Surg 2002; 184: 45-51.
115. Hyman NH, Cataldo P, Osler T. Urgent subtotal colectomy for severe inflammatory bowel disease. Dis Colon Rectum 2005; 48: 70-3.
116. Goes RN, Nguyen P, Huang P, Beart RW. Lengthening of the mesentery using the marginal vascular arcade of the right colon as the blood supply to the pouch. Dis Colon Rectum 1995; 38: 893-5.
117. Mishalany HG. Can the omentum produce intestinal obstruction? J Med Liban 1972; 25: 209-14.
118. Weese JL, Ottery FD, Emoto SE. Does omentectomy prevent malignant small bowel obstruction? Clin Exp Metastasis 1988; 6: 319-24.
119. Araki T, Parc Y, Lefevre J et al. The effect on morbidity of mesentery lengthening techniques and the use of a covering stoma after ileal pouch surgery. Dis Colon Rectum 2006; 49: 621-8.
120. Ambroze WL Jr, Wolff BG, Kelly KA et al. Let sleeping dogs lie: Role of the omentum in ileal pouch-anal anastomosis procedure. Dis Colon Rectum 1991; 34: 563-5.
121. Carter FM, McLeod RS, Cohen Z. Subtotal colectomy for ulcerative colitis: Complications related to the rectal remnant. Dis Colon Rectum 1991; 34: 1005-9.
122. Kyle SM, Steyn RS, Keenan RA. Management of the rectum following colectomy for acute colitis. Aust N Z J Surg 1992; 62: 196-9.
123. Ng RL, Davies AH, Grace RH, Mortensen NJ. Subcutaneous rectal stump closure after emergency subtotal colectomy. Br J Surg 1992; 79: 701-3.
124. Karch LA, Bauer JJ, Gorfine SR, Gelernt IM. Subtotal colectomy with Hartmann's pouch for inflammatory bowel disease. Dis Colon Rectum 1995; 38: 635-9.
125. McKee RF, Keenan RA, Munro A. Colectomy for acute colitis: Is it safe to close the rectal stump? Int J Colorectal Dis 1995; 10: 222-4.
126. Wojdemann M, Wettergren A, Hartvigsen A, Myrhoj T, Svendsen LB, Bulow S. Closure of rectal stump after colectomy for acute colitis. Int J Colorectal Dis 1995; 10: 197-9.
127. Randall J, Bach SP, Sarris I, Mortensen NJ, Jewell DP, Travis SPL, George BD. Complications of the retained rectum after emergency subtotal colectomy for severe ulcerative colitis. Comparison of subcutaneous vs. pelvic closure. Colorectal Dis 2005; 7 (Suppl. 1): 46.
128. Brady RR, Collie MH, Ho GT, Bartolo DC, Wilson RG, Dunlop MG. Outcomes of the rectal remnant following colectomy for ulcerative colitis. Colorectal Dis 2008; 10: 144-50.
129. Wexner SD, Johansen OB, Nogueras JJ, Jagelman DG. Laparoscopic total abdominal colectomy. A prospective trial. Dis Colon Rectum 1992; 35: 651-5.
130. Araki Y, Isomoto H, Tsuzi Y, Matsumoto A, Yasunaga M, Toh U, Yamauchi K, Shirouzu K. Clinical aspects of total colectomy-laparoscopic versus open technique for familial adenomatous polyposis and ulcerative colitis. Kurume Med J 1998; 45: 203-7.
131. Araki Y, Ishibashi N, Ogata Y, Shirouzu K, Isomoto H. The usefulness of restorative laparoscopic-assisted total colectomy for ulcerative colitis. Kurume Med J 2001; 48: 99-103.
132. Dunker MS, Bemelman WA, Slors JF, van Hogezand RA, Ringers J, Gouma DJ. Laparoscopic-assisted vs. open colectomy for severe acute colitis in patients with inflammatory bowel disease (IBD): A retrospective study in 42 patients. Surg Endosc 2000; 14: 911-4.
133. Seshadri PA, Poulin EC, Schlachta CM, Cadeddu MO, Mamazza J. Does a laparoscopic approach to total abdominal colectomy and proctocolectomy offer advantages? Surg Endosc 2001; 15: 837-42.
134. Pokala N, Delaney CP, Senagore AJ, Brady KM, Fazio VW. Laparoscopic vs. open total colectomy: A case-matched comparative study. Surg Endosc 2005; 19: 531-5.
135. Marcello PW, Milsom JW, Wong SK, Brady K, Goormastic M, Fazio VW. Laparoscopic total colectomy for acute colitis: A case-control study. Dis Colon Rectum 2001; 44: 1441-5.
136. Marceau C, Alves A, Ouaissi M, Bouhnik Y, Valleur P, Panis Y. Laparoscopic subtotal colectomy for acute or severe colitis complicating inflammatory bowel disease: A case-matched study in 88 patients. Surgery 2007;141: 640-4.